These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Inhibitory effects of integrin av beta3 monoclonal antibody on implanted lesions of endometriosis model of SCID mouse].
    Author: Zhao J, Zong LL, Li YL.
    Journal: Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):709-11. PubMed ID: 15958316.
    Abstract:
    OBJECTIVE: To explore the potential use of integrin av beta3 (Lm609) monoclonal antibody against ectopic lesion and microvessel angiogenesis of human endometriosis xenografts in SCID mice. METHODS: The endometrial tissues from endometriosis patients were inoculated subcutaneously into SCID mouse, which were treated with Lm609, an inhibitor of angiogenesis, twice a week, for 3 weeks. The mice were sacrificed and immunohistochemical staining was employed to determine the microvessel density (MVD) and expression of integrin av beta3 in the lesion tissues. RESULTS: Lm609 inhibited the growth of the ectopic lesion. The lesion weighted 0.82+/-0.09 g in the treated group versus 0.51+/-0.93 g in the control group (P<0.05). The MVDs of the treated and control groups were 31.2+/-4.4 and 14.4+/-1.8 respectively (P<0.05). CONCLUSION: Lm609 can inhibit the growth of ectopic lesion by reducing angiogenesis in SCID mouse.
    [Abstract] [Full Text] [Related] [New Search]